BNCT (boron neutron capture therapy) is a binary radiation therapy for the treatment of cancer, based on the capture of thermal neutrons by 10B nuclei that have been selectively delivered to tumour cells. The neutron capture event results in the formation of excited 11B nuclei that undergo fission to yield highly energetic 4He2+ and 7Li3+ ions. Cell death is triggered by the release of these charged particles which create ionisation tracks along their trajectories, resulting in cellular damage. It has been estimated that approximately 10−30 μg of boron per gram of tumour mass is needed to attain an acceptable therapeutic advantage.1 An important task relies on the possibility of delivery high payloads of 10B at the target sites and polynuclear boron derivatives are potential candidates for BNCT applications. Several functionalised carboranes have been employed to construct boron delivery vehicles for BNCT, because of their high content of boron and their stability in vivo. In recent years our research group has been working on the preparation of dual agents for BNCT/MRI applications. In these systems a carborane cage is linked to a lipophilic unit, in order to exploit LDLs as biological vectors, and a MRI probe (AT101).2 In vivo MR image acquisition showed that the amount of B taken up in the tumour region was above the threshold for successful NCT treatment.3 With the goal of achieving an effective MRI/GdBNCT agent in a relatively few synthetic passages in mind, we have recently applied the Huisgen reaction carried out in heterogeneous conditions to the suitable substituted carborane cage. MRI images performed on tumour melanoma cells incubated in the presence of the Gd/B dual probe have demonstrated that the high amount of intracellular B necessary to perform BNCT can be reached using a relatively low B containing labelled LDL concentration.

Synthetic strategies for the preparation of lipophilic MRI/GdBNCT agents

TOPPINO, Antonio;DEAGOSTINO, Annamaria;GENINATTI CRICH, Simonetta;ALBERTI, DIEGO;AIME, Silvio;VENTURELLO, Paolo
2012-01-01

Abstract

BNCT (boron neutron capture therapy) is a binary radiation therapy for the treatment of cancer, based on the capture of thermal neutrons by 10B nuclei that have been selectively delivered to tumour cells. The neutron capture event results in the formation of excited 11B nuclei that undergo fission to yield highly energetic 4He2+ and 7Li3+ ions. Cell death is triggered by the release of these charged particles which create ionisation tracks along their trajectories, resulting in cellular damage. It has been estimated that approximately 10−30 μg of boron per gram of tumour mass is needed to attain an acceptable therapeutic advantage.1 An important task relies on the possibility of delivery high payloads of 10B at the target sites and polynuclear boron derivatives are potential candidates for BNCT applications. Several functionalised carboranes have been employed to construct boron delivery vehicles for BNCT, because of their high content of boron and their stability in vivo. In recent years our research group has been working on the preparation of dual agents for BNCT/MRI applications. In these systems a carborane cage is linked to a lipophilic unit, in order to exploit LDLs as biological vectors, and a MRI probe (AT101).2 In vivo MR image acquisition showed that the amount of B taken up in the tumour region was above the threshold for successful NCT treatment.3 With the goal of achieving an effective MRI/GdBNCT agent in a relatively few synthetic passages in mind, we have recently applied the Huisgen reaction carried out in heterogeneous conditions to the suitable substituted carborane cage. MRI images performed on tumour melanoma cells incubated in the presence of the Gd/B dual probe have demonstrated that the high amount of intracellular B necessary to perform BNCT can be reached using a relatively low B containing labelled LDL concentration.
XXXIV CONVEGNO NAZIONALE DIVISIONE DI CHIMICA ORGANICA
Pavia
10-14/09/2012
Atti del Convegno
Società Chimica Italiana
67
67
Antonio Toppino; Annamaria Deagostino; Simonetta Geninatti-Crich; Diego Alberti; Silvio Aime; Paolo Venturello
File in questo prodotto:
File Dimensione Formato  
Pavia2012congresso chimica organicapagina67.pdf

Accesso riservato

Tipo di file: MATERIALE NON BIBLIOGRAFICO
Dimensione 155.57 kB
Formato Adobe PDF
155.57 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/117357
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 32
  • ???jsp.display-item.citation.isi??? ND
social impact